Overview of Antifungal Drugs against Paracoccidioidomycosis: How Do We Start, Where Are We, and Where Are We Going?
Lívia do Carmo Silva(Universidade Federal de Goiás), Maristela Pereira(Universidade Federal de Goiás), Thaynara Gonzaga Santos(Universidade Federal de Goiás), Olívia Basso Rocha(Universidade Federal de Goiás), Raisa Melo Lima(Universidade Federal de Goiás), Amanda Alves de Oliveira(Universidade Federal de Goiás), Kleber Santiago Freitas e Silva(Universidade Federal de Goiás), Dienny Rodrigues de Souza(Universidade Federal de Goiás), Célia Maria de Almeida Soares(Universidade Federal de Goiás), Katheryne Lohany Barros Barbosa(Universidade Federal de Goiás), Marcos Antonio Batista de Carvalho Júnior(Universidade Federal de Goiás)
Cited by 28
Related Papers
Chalcone Derivatives: Promising Starting Points for Drug Design
|Molecules|2017|415
Transcriptional Profiles of the Human Pathogenic Fungus Paracoccidioides brasiliensis in Mycelium and Yeast Cells
|Journal of Biological Chemistry|2005|194
The Genome of Anopheles darlingi , the main neotropical malaria vector
|Nucleic Acids Research|2013|156
New Paracoccidioides brasiliensis isolate reveals unexpected genomic variability in this human pathogen
|Fungal Genetics and Biology|2008|142